Coherus Oncology, Inc.
CHRS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $190,616 | $84,888 | $93,497 | $159,277 |
| - Cash | $103,352 | $216,893 | $82,411 | $125,987 |
| + Debt | $1,946 | $41,029 | $269,927 | $269,904 |
| Enterprise Value | $89,210 | -$90,976 | $281,013 | $303,194 |
| Revenue | $11,571 | $10,254 | $7,599 | $54,144 |
| % Growth | 12.8% | 34.9% | -86% | – |
| Gross Profit | $7,850 | $6,859 | $4,946 | $20,286 |
| % Margin | 67.8% | 66.9% | 65.1% | 37.5% |
| EBITDA | -$41,226 | -$41,569 | -$44,202 | -$44,317 |
| % Margin | -356.3% | -405.4% | -581.7% | -81.9% |
| Net Income | -$35,531 | $297,767 | -$56,569 | -$50,696 |
| % Margin | -307.1% | 2,903.9% | -744.4% | -93.6% |
| EPS Diluted | -0.31 | -0.36 | -0.49 | -0.44 |
| % Growth | 13.9% | 26.5% | -11.4% | – |
| Operating Cash Flow | -$46,339 | -$46,632 | -$25,826 | $28,608 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$46,339 | -$46,632 | -$25,826 | $28,608 |